Signaling pathways
-
A3272 Calcipotriol monohydrateSummary: A synthetic vitamin D3 analogue -
A9078 Z-FY-CHOSummary: Z-FY-CHO is a potent and specific cathepsin L inhibitor. -
A9082 Taurocholic acid-d4Summary: Taurocholic acid-d4 is deuterium labeled Taurocholic acid. It intended for use as an internal standard for the quantification of TCA by GC- or LC-MS. -
A9083 L-Cysteine-¹³C3Summary: L-Cysteine-¹³C3 is the ¹³C-labeled L-Cysteine. It acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans. -
BA2315 PolatuzumabSummary: Polatuzumab is a monoclonal antibody with a chemotherapeutically active molecule. - BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans.
- BA2317 IzeltabartSummary: Izeltabart is a high affinity humanized antibody that targets.
- BA2318 LifastuzumabSummary: Lifastuzumab is a humanized anti-monoclonal antibody (IgG1 type).
- BA2319 BriobaceptSummary: Briobacept (BR3FC) is a selectively targeted monoclonal antibody that induces apoptosis in B cells.
- BA2320 DxdSummary: Dxd (ExatecanderivativeforADC) is a potent inhibitor.